Ewa Fiorentino Rozek: APS – When “Unprovoked” Clots And Pregnancy Loss Connect
Ewa Fiorentino Rozek, Head of Clinical Affairs at AliveDx, shared on LinkedIn:
‘‘Antiphospholipid Syndrome (APS): when “unprovoked” clots and pregnancy loss connect
What it is: An autoimmune pro-thrombotic state causing venous/arterial thromboses and pregnancy morbidity.
It can be primary or overlap with SLE.
Patients often appear “too young” for DVT/PE or stroke; recurrent miscarriage may be the first clue.
Clinical clues: unprovoked DVT/PE, stroke/TIA under 50, livedo reticularis, thrombocytopenia, recurrent early losses or late complications in pregnancy.
Management changes dramatically if APS is confirmed—anticoagulation choices and obstetric planning differ.
Diagnostics (snapshot):
– Antibodies: anticardiolipin (aCL) and anti-β2GPI (IgG/IgM).
– Functional: lupus anticoagulant (LA).
– Key principle: persistence—positive results repeated after ~12 weeks to confirm.”

Stay updated with Hemostasis Today.
-
Jun 13, 2026, 10:04Johanna Gebhart: New Publication from the Vienna Bleeding Biobank Advancing BDUC Research Is Now Live
-
Jun 13, 2026, 08:50Alfadil Haroon: Decoding the Complexity of Factor II Deficiency at EHA 2026
-
Jun 13, 2026, 08:44Omid Seidizadeh: Honored to Present on Advances in VWD Management at EHA 2026
-
Jun 13, 2026, 02:23Ruben Mesa: Honoring MPN Legend Prof. Claire Harrison
-
Jun 13, 2026, 02:09Hassan Raza: ABO Discrepancy Case – Educational Review
-
Jun 12, 2026, 16:40Connie Montgomery about Last Night with Trialport and Global Genes
-
Jun 12, 2026, 16:20Tejas Ahire: When the Body’s Clotting System Goes Out of Control
-
Jun 12, 2026, 16:14Chokri Ben Lamine: EHA26 – SCD Curative Therapy Pathway
-
Jun 12, 2026, 16:13Talha Badar: Excellent Talk by Francesca Palandri on ET and PV at EHA 2026